REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 1 filers reported holding REDHILL BIOPHARMA LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | -100.0% | 200 | -98.8% | 0.00% | -100.0% |
| Q4 2021 | $32,000 | -8.6% | 17,000 | -50.4% | 0.00% | 0.0% |
| Q3 2021 | $35,000 | +3400.0% | 34,300 | +5616.7% | 0.00% | – |
| Q1 2021 | $1,000 | – | 600 | -70.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 2,000 | -45.9% | 0.00% | -100.0% |
| Q3 2020 | $20,000 | 0.0% | 3,700 | -47.1% | 0.00% | 0.0% |
| Q2 2020 | $20,000 | +53.8% | 7,000 | +122.4% | 0.00% | 0.0% |
| Q1 2020 | $13,000 | +44.4% | 3,148 | +96.8% | 0.00% | 0.0% |
| Q4 2019 | $9,000 | 0.0% | 1,600 | +14.3% | 0.00% | 0.0% |
| Q3 2019 | $9,000 | +800.0% | 1,400 | +366.7% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 300 | -76.9% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 1,300 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | – | 1,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |